imatinib mesylate has been researched along with Urinary Retention in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adesunkanmi, AO; Lawal, AO; Mustapha, B; Ndegbu, CU; Odunafolabi, TA; Olasehinde, O; Olorunsola, IS | 1 |
| Blyweert, W; De Ridder, D; Debiec-Rychter, M; Ost, D; Sciot, R; Van der Aa, F; Van Oosterom, A; Van Poppel, H | 1 |
2 other study(ies) available for imatinib mesylate and Urinary Retention
| Article | Year |
|---|---|
Rectal gastrointestinal stromal tumor: an unusual presentation of an uncommon pathology (a case report).
Topics: Adult; Antigens, CD34; Antineoplastic Agents; Combined Modality Therapy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Obstruction; Male; Proto-Oncogene Proteins c-kit; Rectal Neoplasms; Urinary Retention | 2021 |
Gastrointestinal stromal tumor of the prostate.
Topics: Acute Disease; Amino Acid Substitution; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Mutation, Missense; Neoplasm Proteins; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography; Sarcoma; Urinary Retention; Weight Loss | 2005 |